/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
United-Guardian, Inc. ( Company ) is a Delaware corporation that, through its Guardian Laboratories division, manufactures, markets and develops specialty cosmetic, personal care and sexual wellness ingredients and a line of healthcare products including pharmaceuticals and medical lubricants. Our R&D department primarily develops new and unique specialty cosmetic and sexual wellness ingredients.
$7.13
$0.11 (-1.52%)
EOD Sep 1, 2026
21.27% operating margin is above average. ROIC at 14.76%.
Revenue declined 13.4% YoY. Margins deteriorated 8.7pp alongside, both lines moving the wrong way.
Free cash flow declined 37% versus the prior year, cash generation momentum has weakened. ROIC dropped from 23.97% to 14.76%, capital efficiency is deteriorating.
13.3x earnings, 9.6x FCF. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$11M
▼ -13.4% YoY
Net Income (TTM)
$2M
▼ -35.2% YoY
Op. Margin
20.82%
▼ -8.7pp YoY
ROIC
15.37%
▼ -9.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$3M
▼ -37.1% YoY
Op. Cash Flow (TTM)
$3M
▼ -43.3% YoY
Net Debt
-$10M
Net Cash Position
Cash & Equiv.
$10M
5Y CAGR: -0.8%
5Y CAGR: -11.7%
Continue Research
SourceComputed from the 10-Q filed 11 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 12 Aug 2026. How this is calculated.
Price from market data, last close as of 1 Sept 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.
At a P/E of 13.3 and a price-to-free-cash-flow of 9.6, United-Guardian (UG) trades below a two-stage DCF intrinsic value of about $14.91 per share, so at $7.13 the stock looks undervalued (109.1% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, United-Guardian scores 61/100 on Intrinsiqq's quality scorecard (a solid business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 7.0%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $14.91 per share for UG, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $11.18. At today's $7.13, that puts the stock about 109.1% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
United-Guardian scores 61 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a solid business on these measures. Recent fundamentals include a 20.8% operating margin and a 15.4% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, United-Guardian pays a regular dividend of about $0.50 per share per year (typically in quarterly installments), a yield of roughly 7.0% at the current price. That is a payout ratio of about 93.2% of earnings, so the dividend is stretched at this level. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For UG's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. UG currently trades below its estimated intrinsic value and scores 61/100 on quality (solid). It also yields about 7.0%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.